Drugs / FluoAB
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT05394246 | May 2022 → Dec 2024 | liver cancer | Chinese Academy of Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluoAB | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05394246 ↗ |
| Modality | Diagnostic / imaging agent | “intraoperative fluorescence imaging using fluorescent-labeled IgG probe (FluoAB)” NCT05394246 ↗ |